Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Noradrenaline versus phenylephrine infusion during spinal anesthesia for cesarean delivery
ACTRN12618000244202Phase 3Completed
- Sponsor
- Women's Wellness and Research Center
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in maternal hypotension comparing Noradrenaline infusion with Phenylephrine infusion (2 arms). Primary endpoints: Median effective dose (ED50) of noradrenaline and phenylephrine and Relative potency ratio of noradrenaline to phenylephrine. Started Feb 2018; status: completed.
02
Drugs
norepinephrinephenylephrine
03
Conditions
maternal hypotension
Beyond the preview
Go deeper on ACTRN12618000244202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000244202.